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O B J E C T I V E S To evaluate the accuracy of adenosine myocardial contrast echocardiography (MCE)
in diagnosing coronary artery disease (CAD).
B A C KG ROUND Adenosine stress echocardiography is not routinely used in the assessment of
CAD. Since ultrasound microbubble contrast agents enable improved wall motion analysis and
simultaneous assessment of myocardial perfusion, we sought to evaluate the diagnostic performance of
combinedwall motion/perfusion imaging with adenosineMCE in patients with suspected CAD. We evaluated
the accuracy of adenosine MCE in identifying 1) the presence of anatomic disease, as deﬁned by X-ray
angiography, and 2) the functional signiﬁcance of CAD, as determined by high ﬁeld-strength (3-T),
multiparametric cardiac magnetic resonance (CMR) imaging.
METHOD S Sixty-ﬁve patients with suspected CAD were studied before angiography with MCE and
CMR, at stress (140 g/kg/min intravenous adenosine) and at rest. For MCE, 2-, 3- and 4-chamber
long-axis images were acquired during intravenous sulfur hexaﬂuoride infusion. For CMR, short-axis
ﬁrst-pass perfusion and delayed enhancement images were acquired following intravenous gadolinium–
diethylenetriaminepentaacetic acid bolus injections (0.05 mmol/kg). Quantitative coronary angiography
served as a reference standard for anatomic disease (signiﬁcant CAD deﬁned as 50% reference
diameter in vessels with diameter 2 mm).
R E S U L T S Compared with X-ray angiography, MCE provided diagnostic accuracy of 82%, sensitivity
of 85%, and speciﬁcity of 76% for detecting signiﬁcant coronary stenosis. Disease location was also
identiﬁed with reasonable accuracy (diagnostic accuracy 81% for left anterior descending disease, 77%
for left circumﬂex artery disease, and 84% for right coronary artery disease). With CMR as the reference
standard for functional assessment, MCE provided diagnostic accuracy of 79%, sensitivity of 85%, and
speciﬁcity of 74%. Interobserver agreement for MCE was 79% (95% conﬁdence interval: 67% to 88%).
CONC L U S I O N S Adenosine MCE achieved favorable diagnostic performance in identifying the
presence and functional signiﬁcance of coronary stenosis. Adenosine MCE may be useful in the clinical
setting for evaluating patients with suspected CAD. (J Am Coll Cardiol Img 2010;3:934–43) © 2010 by
the American College of Cardiology Foundation
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935efining the presence and functional signifi-
cance of coronary artery stenosis is of
critical importance in the management of
patients with coronary artery disease
CAD). Owing to the invasive and costly nature of
oronary angiography, there is a compelling need
or reliable, noninvasive techniques for the purpose
f diagnosis and risk stratification.
See page 944
The diagnostic and prognostic roles of perfusion
maging with single-photon emission computed
omography (SPECT) and cardiac magnetic reso-
ance (CMR) are well established (1–5). Because
erfusion deficits arise early in the ischemic cascade,
he induction and detection of perfusion defects
ith both of these imaging modalities constitute a
afe and sensitive means for detecting CAD (6).
ompared with SPECT, key advantages of CMR
nclude its superior spatial resolution and the avoid-
nce of exposure to ionizing radiation (7). More-
ver, the performance of CMR perfusion imaging
ay be further augmented with the use of higher
eld strengths or by a multiparametric approach
ncorporating late gadolinium enhancement imag-
ng (8,9).
An alternative to perfusion imaging techniques
s wall motion imaging, such as dobutamine stress
chocardiography (10). The diagnostic and prog-
ostic roles of this technique are also well docu-
ented (11,12). However, because contractile
ysfunction occurs later in the ischemic cascade,
harmacologic induction of wall motion abnor-
ality presents greater hazard to the patient and
esults in severe adverse effects in a minority of
atients (13).
The recent advent of second-generation ultra-
ound microbubble contrast agents now enables
erfusion imaging with echocardiography (14,15).
rom the *University of Oxford Centre for Clinical Magnetic Resonance
esearch, John Radcliffe Hospital, Oxford, United Kingdom; †Military
edical Institute, Warsaw, Poland; ‡Department of Cardiology, John
adcliffe Hospital, Oxford, United Kingdom; §Department of Cardio-
ascular Medicine, Northwick Park Hospital, Harrow, United Kingdom;
nd the Department of Cardiovascular Medicine, Flinders Medical
entre, Adelaide, Australia. This work was supported by the British
eart Foundation, the UK Medical Research Council, and the Oxford
artnership Comprehensive Biomedical Research Centre with funding
rom the Department of Health’s NIHR Biomedical Research Centers
unding scheme. Dr. Becher has received research funds and has served on
he Speakers’ Bureau for Philips. All other authors report that they have
o relationships to disclose.e
anuscript received January 21, 2010; revised manuscript received June 3,
010, accepted June 4, 2010.dvantages of this technique include high spatial
nd temporal resolution, in addition to the wide
vailability and portability of echocardiography.
yocardial contrast echocardiography (MCE) us-
ng dipyridamole has been evaluated in recent trials,
uggesting performance equivalent to or even supe-
ior to that of SPECT imaging (14,16). Adenosine
s an alternative pharmacologic stressor, whose di-
gnostic role and excellent safety profile are already
ell documented in SPECT and CMR perfusion
maging (1–4,17–19). Yet, compared with dipyri-
amole, adenosine has the key advantage of a
horter half-life, which minimizes adverse effects
nd facilitates a more time-efficient examination.
erfusion imaging with adenosine is a relatively
ew application, and the use of contrast for this
urpose has yet to receive approval. Previous studies
valuating adenosine MCE are few in number and
f small size, and methodologic limitations leave
nresolved the question of the clinical utility of this
echnique (20–26).
We hypothesized that a simplified
denosine MCE protocol could form the
asis of a rapid but accurate diagnostic test
or CAD in the clinical setting. Accord-
ngly, we prospectively evaluated its accu-
acy in identifying the presence and func-
ional significance of CAD. As reference
tandards, we used 1) diagnostic coronary
ngiography to define anatomic CAD and
) high field-strength, multiparametric
MR imaging to determine the func-
ional significance of CAD.
E T H O D S
atient population. We prospectively recruited 65
atients, 18 to 80 years of age, who had been
eferred to the regional tertiary center for elective
iagnostic angiography as part of routine clinical
are for further investigation of exertional chest
ain. Exclusion criteria were recent myocardial
nfarction (within 7 days) and contraindications to
MR (severe claustrophobia, metallic implants/
oreign bodies), adenosine (second-/third-degree
trioventricular block, obstructive pulmonary dis-
ase, dipyridamole use), gadolinium (anaphylaxis,
stimated glomerular filtration rate 60 ml/min),
nd sulfur hexafluoride (previous allergic reaction).
he CMR and MCE examinations were under-
aken on the same day, in random order. Patients
ere asked to avoid caffeine for 24 h before their
A B B
A N D
CAD
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enhan
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echoc
MI
SPECT
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936ere continued. The study was conducted accord-
ng to the Declaration of Helsinki and was ap-
roved by the regional ethics committee. All par-
icipants gave written informed consent before
articipation.
chocardiography protocol. Each patient underwent
CE examination (IE33, Philips Ultrasound, An-
over, Massachusetts) using an S3 transducer and
he preset low mechanical index (MI) imaging in
ower modulation mode (operating frequency 2.5
Hz). The default MI was 0.10, with small vari-
tion (0.09 to 0.15) according to the imaging depth.
peripheral infusion of sulfur hexafluoride
Sonovue, Bracco Diagnostics Inc., Milan, Italy)
as commenced at 0.7 ml/min and adjusted in
.1-ml/min steps to achieve optimum myocardial
pacification. Optimum myocardial opacification
as defined as homogeneous left ventricular opaci-
cation combined with at least mild homogeneous
pacification of myocardial segments without atten-
ation or shadow artifacts. Once “steady state” was
eached, resting images were acquired in the 3
pical long-axis views. Single-beat loops were ac-
uired during short breath holds and were stored
igitally. For stress imaging, intravenous adenosine
140 g/kg/min) was administered for 4 minutes,
r less if angina was induced or if perfusion/wall
otion abnormalities became apparent. During the
nfusion, the same imaging dataset (comprising 2-,
-, and 4-chamber apical views) was sequentially
cquired at approximately 1-min intervals, with
torage of multiple cineloops for each view. Patients
ere monitored continuously by electrocardiogra-
hy, sphygmomanometry, and pulse oximetry.
MR protocol. The CMR examination at 3-T (Trio,
iemens Medical Solutions, Malvern, Pennsylva-
ia) was performed using anterior and posterior
hased-array coils. From standard piloting, short-
xis cine images covering the left ventricle were
cquired using an electrocardiography (ECG)-
ated steady-state free precession sequence (echo
ime 1.5 ms, repetition time 3 ms, flip angle 60o,
lice thickness 7 mm, slice gap 3 mm). Off-
esonance artifacts were minimized by shim adjust-
ents and changes in synthesizer frequency.
For CMR perfusion imaging, patients were
onitored continuously by ECG, sphygmoma-
ometry, and pulse oximetry. After 4 min of intra-
enous adenosine (140 g/kg/min), or fewer if
ngina was induced, a 0.05-mmol/kg bolus of
adolinium-based contrast (gadodiamide, Omnis-
an, GE Healthcare, Princeton, New Jersey) was
njected, followed by 15 ml of normal saline at a rate ff 6 ml/s. During the first pass of contrast, 3 to 4
hort-axis images were acquired every cardiac cycle
sing an ECG-gated T1-weighted fast gradient
cho sequence with generalized autocalibrating par-
ially parallel acquisitions reconstruction (echo time
.04 ms, repetition time 2 ms, saturation recovery
ime 100 ms, voxel size 2.1  2.6  8 mm3, flip
ngle 17o, slice thickness 8 mm). During imaging,
atients were instructed to hold their breath as long
s possible in end-expiration. After 20 min, the
ame sequence was repeated without adenosine for
esting perfusion.
For late gadolinium enhancement (LGE) imag-
ng, following a further bolus of gadodiamide (0.05
mol/kg) and after a 5-min delay, images were
cquired in 3 long-axis and all short-axis planes,
sing a T1-weighted segmented inversion-recovery
urbo fast low-angle shot sequence (echo time 4.8
s, voxel size 1.4  2.4  8 mm3, flip angle 20°,
lice thickness 8 mm). The inversion time was
djusted to obtain optimal nulling of noninfarcted
yocardium.
oronary angiography. Within 2 weeks of the CMR
nd MCE examinations, all patients underwent
oronary angiography using standard techniques.
mages of the coronary arteries were obtained in
ultiple projections, avoiding overlap of side
ranches and foreshortening of relevant coronary
tenoses.
chocardiography analysis. Echocardiography scans
ere visually interpreted in random order by a
ingle observer blinded to clinical information, an-
iographic data, and CMR results. Assessment of
all motion and perfusion was performed using the
7-segment American Heart Association model
27). For wall motion assessment, standard seg-
ental scoring was performed (1  normal, 2 
ypokinesis, 3  akinesis, 4  dyskinesis), with
ocumentation of progression of wall motion ab-
ormality during stress. For perfusion assessment,
est and stress images were displayed side by side. A
erfusion defect was defined as a decrease in con-
rast enhancement relative to another region with
omparable image quality. Perfusion defects were
onsidered artifactual if there were attenuation de-
ects, contrast shadowing, or artifacts from external
hadowing. Inducible ischemia was defined as a
tress perfusion defect appearing more extensive
han at rest, or progression of resting wall motion
bnormality. The diagnosis of CAD was deter-
ined by the presence of 1) resting akinesis;
) reversible wall motion abnormalities; or 3) per-
usion defects (fixed or reversible). Ischemia was
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937efined as the presence of reversible regional wall
otion abnormalities or reversible perfusion de-
ects. For the identification of disease location, a
ositive diagnosis was determined by the presence
f perfusion/wall motion abnormality in any seg-
ent ascribed to a coronary artery according to
tandardized criteria (27). The assessment of CAD
everity was determined according to whether
ingle-vessel and multivessel disease were classified
orrectly. The overall diagnosis of CAD, on a per
atient basis, was determined by the presence of any
bnormal segment.
nterobserver agreement. To assess interobserver
greement, all MCE images were interpreted by a
econd blinded reader. Interobserver agreement was
ssessed on per-patient and per-vessel bases. For
MR and diagnostic angiography, interobserver
greement per vessel was also assessed.
MR analysis. CMR scans were visually interpreted
n random order by a single blinded reader with
ssessment of resting wall motion, LGE, and per-
usion on separate days. Perfusion and LGE data
ere subsequently combined according to the algo-
ithm described by Klem et al. (9).
For perfusion assessment, stress and rest perfu-
ion scans were magnified and displayed simulta-
eously and analyzed using criteria previously de-
cribed (8). For resting wall motion assessment,
tandard segmental scoring was performed (1 
ormal, 2  hypokinesis, 3  akinesis, 4 
yskinesis). For LGE assessment, segments were
raded as abnormal or normal. The diagnosis of
AD was determined on a segmental basis by the
resence of either perfusion abnormalities or LGE
9). For MCE analysis, a segmental approach was
sed to determine CAD severity and location. The
unctional significance of coronary stenosis was
etermined by concurrent analysis of perfusion and
GE images; ischemia was defined as stress perfu-
ion defects more extensive than resting perfusion
efects/LGE.
ngiographic analysis. Quantitative coronary angiog-
aphy was performed by a single blinded reader. Each
yocardial segment was ascribed a coronary artery
erritory according to standard criteria (27). Diameters
f reference and stenotic coronary arteries were mea-
ured by a computer-assisted quantitative method
Axiom Artis QCA software, Siemens). The contrast-
lled catheter was used for image magnification cali-
ration. Significant CAD was defined angiographi-
ally as 50% stenosis in any epicardial coronary
rtery/branch with diameter 2 mm.tatistical analysis. Data analysis was performed us-
ng Medcalc 9.1.0.1 (Medcalc, Mariakerke, Bel-
ium). Discrete data were compared using Mc-
emar tests and chi-square or Fisher exact test as
ppropriate.
E S U L T S
tudy population. From a total of 99 consecutive
atients screened, 65 elected to participate in the
tudy. Two patients did not undergo CMR examina-
ion owing to claustrophobia, and one subsequently
ithdrew consent; thus, 62 patients completed both
cans and were included in the final analysis. Baseline
atient characteristics are outlined in Table 1.
In total, 41 of 62 patients (66%) had angio-
raphically defined stenosis 50% (mean diameter
tenosis  SD 74  20%) and 29 of 62 (47%) had
70% stenosis. Of the whole cohort, 21 of 62 (34%)
ad single-vessel and 20 of 62 (32%) had multivessel
isease. Thirty-one patients (50%) had significant
Table 1. Baseline Clinical Characteristics
Variables
Entire Group
(n  62)
No CAD
(n  21)
Men 40 (65) 7 (33)
Age (yrs) 64 9 63 6
BMI (kg/m2) 28 5 28 6
Risk factors
Current smoker 6 (10) 2 (10)
Ex-smoker 20 (32) 6 (29)
Hypertension 33 (53) 8 (38)
Hypercholesterolemia 35 (57) 10 (48)
Diabetes mellitus 11 (18) 2 (10)
Family history of CAD 22 (36) 10 (48)
Medications
Aspirin 55 (89) 17 (81)
Statin 52 (84) 15 (71)
Beta-blocker 41 (66) 15 (71)
Calcium blocker 21 (34) 5 (24)
Nitrate 9 (15) 3 (14)
ACE inhibitor 32 (52) 6 (29)
Left ventricular function
Ejection fraction (%) 62 12 66 10
End-diastolic volume index (ml/m2) 77 18 69 15
End-systolic volume index (ml/m2) 30 8 24 12
Stroke volume index (ml/m2) 46 8 45 9
Mass index (g/m2) 65 19 62 24
Presence of resting regional wall
motion abnormality
26 (42) 3 (14)
Presence of LGE 19 (31) 1 (5)
Values are n (%) or mean  SD.
ACE  angiotensin-converting enzyme; BMI  body mass index; CAD  coroCAD
(n  41)
33 (80)
64 10
29 4
4 (10)
14 (34)
25 (61)
25 (61)
9 (22)
12 (29)
38 (93)
37 (90)
26 (63)
16 (39)
6 (15)
26 (63)
60 12
81 19
34 17
47 9
66 14
23 (56)
18 (44)
nary artery
disease; LGE  late gadolinium enhancement.
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938isease of the left anterior descending artery, 20
atients (32%) had left circumflex disease, and 18
atients (29%) had right coronary artery disease.
sing CMR as the gold standard for ischemia assess-
ent, 27 of 62 patients (44%) had evidence of
nducible ischemia. On a per-vessel basis, 34 of 186
essels demonstrated inducible ischemia.
No significant adverse events occurred during
ither scan, and no clinical cardiac events occurred
n the period between the scans and coronary
ngiography (median interval 7 days; interquartile
ange 6 to 14 days).
mage analysis and quality. For MCE, no patient
as excluded owing to inadequate imaging win-
ows. All wall motion images were deemed satis-
actory, but perfusion images were suboptimal in 1
can. All CMR perfusion images were of sufficient
uality for analysis, and no images were excluded.
etection of anatomically signiﬁcant CAD by MCE.
sing quantitative coronary angiography as the
eference standard for determining the presence of
AD, MCE achieved a diagnostic accuracy of 82%,
ith sensitivity of 85% and specificity of 76%.
isease location was also identified with good
ccuracy (diagnostic accuracy 81% for left anterior
escending disease, 77% for left circumflex disease,
nd 84% for right coronary artery disease). Table 2
emonstrates that the success of MCE was chiefly
ue to the high sensitivity of perfusion assessment
76%); the addition of stress wall motion to perfu-
ion resulted in a further increase in sensitivity but
marginal decrease in specificity.
To gauge the performance of MCE against
nother noninvasive test, we evaluated the ability of
MR imaging (using combined perfusion/LGE
ssessment) to identify angiographically significant
erformance of CMR and MCE Components in the Detection of CA
MCE
Sensitivity Speciﬁcity Accuracy
% 85% (70%–94%) 76% (53%–92%) 82% (70%–91%
76% (60%–88%) 81% (58%–95%) 77% (65%–87%
61% (45%–76%) 86% (64%–97%) 69% (56%–80%
70% 97% (82%–100%) 64% (45%–80%) 79% (67%–88%
90% (73%–98%) 73% (54%–87%) 81% (69%–90%
76% (56%–90%) 82% (65%–93%) 79% (67%–88%
ercentage (95% conﬁdence intervals).
resonance; MCE  myocardial contrast echocardiography; other abbreviations aisease. Perfusion imaging with CMR achieved Cigh sensitivity, albeit with low specificity, but the
atter was augmented by the addition of LGE
ssessment (sensitivity for the combined assessment
0%, specificity 81% [Table 2]). When compared
ith CMR, MCE achieved comparable results for
he overall detection of CAD (diagnostic accuracy
7% for CMR vs. 82% for MCE, p  0.61;
ensitivity 90% vs. 85%, p  0.73; and specificity
1% vs. 76%, p  1.00). Similarly, as illustrated in
able 3, there were no significant differences in the
iagnostic accuracy of the 2 techniques in identify-
ng the extent and distribution of CAD. Figures 1
nd 2 depict patient examples from the study.
etection of inducible ischemia by MCE. Inducible
schemia was identified by CMR in 11.0% of seg-
ents and by MCE in 7.4% of segments (p 0.006).
sing CMR imaging as the reference standard for
unctional assessment, MCE achieved sensitivity of
5% and specificity of 74%, with diagnostic accuracy
f 79%. On a per-vessel basis, MCE correctly identi-
ed 76% of CMR-defined ischemic territories and
9% of normal territories (diagnostic accuracy 87%).
n territories subtended by intermediate-grade steno-
is (50% to 69%), MCE correctly identified 67% of
hose with ischemia and 84% of those without isch-
mia (diagnostic accuracy 77%).
nterobserver variability. For the overall diagnosis of
AD, on a per-patient basis, the interobserver
greement for MCE was 79% (95% confidence
ntervals [CI] 67% to 88%). On a per-vessel basis,
nterobserver agreement was 81% (95% CI 75% to
7%). Complete results for both observers are listed
n Table 4. On a per-vessel basis, interobserver
greement for CMR was 82% (95% CI: 75% to
7%) and for diagnostic angiography was 96% (95%
CMR
Sensitivity Speciﬁcity Accuracy
90% (77%–97%) 81% (58%–95%) 87% (76%–94%)
95% (83%–99%) 62% (38%–82%) 84% (72%–92%)
44% (28%–60%) 95% (76%–100%) 61% (48%–73%)
97% (82%–100%) 61% (42%–77%) 77% (65%–87%)
100% (88%–100%) 45% (28%–64%) 71% (58%–82%)
48% (30%–67%) 85% (68%–95%) 68% (55%–79%)
Table 1.Table 2. Diagnostic P D
Coronary stenosis 50 )
Individual techniques
Perfusion )
Stress wall motion )
LGE-CMR
Coronary stenosis  )
Individual techniques
Perfusion )
Stress wall motion )
LGE-CMR
Proportions expressed as pI: 92% to 98%).
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939I S C U S S I O N
he principal finding in this prospective study is
hat adenosine MCE identifies coronary stenosis
nd its functional significance with favorable diag-
ostic accuracy. Moreover, the performance of
CE in detecting significant anatomic disease is
omparable with that of high field-strength, mul-
iparametric CMR. Notably, adenosine MCE is a
imple bedside investigation which can be per-
ormed within 10 min, highlighting the potential
Table 3. Performance of CMR and MCE for Detecting Signiﬁcant
CMR
CAD
Sensitivity 90% 37/41 (77–97)
Speciﬁcity 81% 17/21 (58–95)
DA 87% 54/62 (76–94)
PPV 90% 37/41 (77–97)
NPV 81% 17/21 (58–95)
SVD
Sensitivity 57% 12/21 (34–78)
Speciﬁcity 98% 40/41 (87–100)
DA 84% 52/62 (72–92)
PPV 92% 12/13 (64–100)
NPV 82% 40/49 (68–91)
MVD
Sensitivity 90% 18/20 (68–99)
Speciﬁcity 76% 32/42 (61–88)
DA 81% 50/62 (69–90)
PPV 64% 18/28 (44–81)
NPV 94% 32/34 (80–99)
LAD
Sensitivity 84% 26/31 (66–95)
Speciﬁcity 77% 24/31 (59–90)
DA 81% 50/62 (69–90)
PPV 79% 26/33 (61–91)
NPV 83% 24/29 (64–94)
LCx
Sensitivity 70% 14/20 (46–88)
Speciﬁcity 86% 36/42 (71–95)
DA 81% 50/62 (69–90)
PPV 70% 14/20 (46–88)
NPV 86% 36/42 (71–95)
RCA
Sensitivity 94% 17/18 (73–100)
Speciﬁcity 75% 33/44 (60–87)
DA 81% 50/62 (69–90)
PPV 61% 17/28 (41–79)
NPV 94% 33/34 (85–100)
Proportions are expressed as percentage/fraction (95% CI).
CI  conﬁdence intervals; DA  diagnostic accuracy; LAD  left anterior desce
value; PPV  positive predictive value; RCA  right coronary artery; SVD  smtility of this technique in the clinical setting. dIn the last decade, refinements in ultrasound
echnology and contrast media have expanded the
ole of echocardiography in the assessment of
AD (15). Whereas harmonic imaging causes
estruction of contrast agents, newer techniques
uch as power modulation and power pulse in-
ersion, which use a low MI, permit real-time
erfusion imaging (15). Improved endocardial
order delineation with contrast also facilitates
he detection of subtle wall motion abnormalities
nd is advantageous during stress, owing to
D
MCE p Value
85% 35/41 (70–94) 0.73
76% 16/21 (53–92) 1.00
82% 51/62 (70–91) 0.61
88% 35/40 (73–96) 0.97
73% 16/22 (50–89) 0.78
67% 14/21 (43–85) 0.75
76% 31/41 (60–88) 0.01
73% 45/62 (60–83) 0.19
58% 14/24 (37–78) 0.07
82% 31/38 (66–92) 0.79
60% 12/20 (36–81) 0.07
90% 38/42 (77–97) 0.07
81% 50/62 (69–90) 1.00
75% 12/16 (48–93) 0.69
83% 38/46 (69–92) 0.13
74% 23/31 (55–88) 0.51
87% 27/31 (70–96) 0.55
81% 50/62 (69–90) 0.62
85% 23/27 (55–88) 0.76
77% 27/35 (60–90) 0.81
60% 12/20 (36–81) 0.69
86% 36/42 (71–95) 1.00
77% 48/62 (65–87) 0.79
67% 12/18 (41–87) 0.90
82% 36/44 (67–92) 0.84
67% 12/18 (41–87) 0.06
91% 40/44 (78–97) 0.09
84% 52/62 (72–92) 0.81
75% 12/16 (48–93) 0.53
87% 40/46 (74–95) 0.23
; LCx  left circumﬂex; MVD  mitral valve disease; NPV  negative predictive
essel disease; other abbreviations as in Table 2.CA
ndingifficulties posed by cardiac and respiratory mo-
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940ion. Furthermore, interobserver agreement is
ignificantly greater with contrast-enhanced than
ith unenhanced echocardiography (28). How-
ver, despite the benefits of contrast, perfusion
maging remains operator dependent, for both
erformance and interpretation of studies, and
Figure 1. Examples Showing CMR and MCE Studies
Case 1 (LAD and LCx disease): short-axis CMR images show absent
eral wall (arrows). Corresponding long-axis MCE images demonstra
tum, apex, and lateral wall (arrows). Case 2 (proximal LAD stenosis)
perfusion defect (arrows); long axis 2-chamber MCE images show a
CMR  cardiac magnetic resonance; LAD  left anterior descendin
myocardial contrast echocardiography.
Figure 2. More Examples Showing CMR and MCE Studies
Case 3 (no signiﬁcant CAD): short-axis CMR images show absent LG
MCE images demonstrate normal perfusion at rest and at stress. Ca
with corresponding perfusion defect (arrowheads), and correspond
abnormality both at rest (arrowheads) and at stress (arrows). CAD
ations as in Figure 1.ay be affected by image attenuation and the
vailability of suitable acoustic windows.
The utility of adenosine MCE using second-
eneration contrast media has been compared with
PECT imaging in a number of studies, suggesting
quivalent or superior diagnostic accuracy (20–25).
but stress perfusion defects in the septum (arrowheads) and lat-
versible perfusion defect and wall motion abnormality in the sep-
rt-axis CMR images show anterior LGE and corresponding
l akinesis at rest and anteroapical stress perfusion defect (arrows).
x  left circumﬂex; LGE  late gadolinium enhancement; MCE 
d homogeneous uptake of gadolinium. Corresponding long-axis
(RCA stenosis): short-axis CMR images show inferior wall LGE
MCE images show inferior wall perfusion defect and wall motion
oronary artery disease; RCA  right coronary artery; other abbrevi-LGE
te re
: sho
pica
g; LCE an
se 4
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941hese studies reported 76% to 92% concordance
ith SPECT by territory, which is comparable to
he 79% found in our study involving CMR (20,22–
4). Similarly, studies comparing MCE with coro-
ary angiography have reported 71% to 92% diag-
ostic accuracy as compared with 82% in our study
20,21,24–26). However, many of these earlier
tudies did not undertake angiography in all pa-
ients, or included populations with a high preva-
ence of CAD or select patient groups (e.g., acute
oronary syndromes, left bundle branch block, hy-
ertension) (20–26). Only one of these studies
ncorporated wall motion assessment in addition to
erfusion, and 94% of subjects had CAD in this
tudy (26). In our study, we assessed both wall
otion and perfusion with adenosine MCE, and to
ur knowledge, this is the first systematic study to
ompare MCE with CMR. In contrast to previous
tudies, a major strength of our study is the inter-
ediate prevalence of CAD in our cohort (signifi-
ant coronary stenosis in 66% and inducible isch-
mia in 44%). We minimized referral bias by
xcluding patients with a high pre-test probability of
AD (e.g., patients with an established diagnosis of
oronary artery stenosis) and subjects with low pre-test
robability (e.g., normal volunteers or individuals with
reviously normal angiography), which may artificially
istort sensitivity or specificity.
Previous studies investigating the role of CMR
erfusion (predominantly at 1.5-T) have substanti-
ted its diagnostic utility (4). Advantages of CMR
maging include its multiparametric nature (allow-
ng for the concurrent measurement of function,
natomy, and viability together with perfusion), its
igh spatial resolution, and its capability for com-
lete coverage of the heart. However, perfusion
maging with CMR can be adversely affected by the
resence of artifacts because of susceptibility differ-
nces, motion, and arrhythmia. Klem et al. (9)
howed that a multiparametric approach combining
oth perfusion and LGE imaging in a visual inter-
retation algorithm further augments the diagnostic
ccuracy of CMR perfusion imaging. Recent work
as also confirmed the superiority of higher field
trengths (3-T vs. 1.5-T), by virtue of increased
ignal-to-noise and contrast-to-noise ratios (8). The
MR results of our study confirm the findings of
lem et al. (9) that LGE imaging augments the
iagnostic capacity of perfusion imaging alone, by
acilitating the differentiation of true perfusion defects
rom artifacts. However, in our study, as may be
xpected with the higher field strength, we report
reater sensitivity for perfusion imaging at 3-T. ntudy limitations. Although X-ray angiography was
sed as the gold standard for determining the
ignificance of coronary artery stenosis, correlation
etween endoluminal appearances and ischemia is
mprecise, particularly in the presence of collateral-
zation or microvascular dysfunction. Moreover,
wing to interindividual variation, standardized
egmentation does not necessarily correlate with
oronary territory. Our study involved exclusively
atients referred for diagnostic angiography; there-
ore, the findings in this study may not necessarily
pply to populations with a lower pretest probability
f disease. Quantitative MCE or CMR analysis was
Table 4. Comparison of MCE Results for the 2 Readers
Echo 1 95% CI Echo 2 9
CAD
Sensitivity 85% (70%–94%) 83% (68
Speciﬁcity 76% (53%–92%) 76% (53
DA 82% (70%–91%) 81% (69
PPV 88% (73%–96%) 87% (73
NPV 73% (50%–89%) 70% (47
SVD
Sensitivity 67% (43%–85%) 76% (53
Speciﬁcity 76% (60%–88%) 83% (68
DA 73% (60%–83%) 81% (69
PPV 58% (37%–78%) 70% (47
NPV 82% (66%–92%) 87% (73
MVD
Sensitivity 60% (36%–81%) 65% (41
Speciﬁcity 90% (77%–97%) 93% (81
DA 81% (69%–90%) 84% (72
PPV 75% (48%–93%) 81% (54
NPV 83% (69%–92%) 85% (71
LAD
Sensitivity 74% (55%–88%) 74% (55
Speciﬁcity 87% (70%–96%) 81% (63
DA 81% (69%–90%) 77% (65
PPV 85% (55%–88%) 79% (60
NPV 77% (60%–90%) 76% (58
LCx
Sensitivity 60% (36%–81%) 70% (46
Speciﬁcity 86% (71%–95%) 83% (69
DA 77% (65%–87%) 79% (66
PPV 67% (41%–87%) 67% (43
NPV 82% (67%–92%) 85% (71
RCA
Sensitivity 67% (41%–87%) 61% (36
Speciﬁcity 91% (78%–97%) 98% (88
DA 84% (72%–92%) 87% (76
PPV 75% (48%–93%) 92% (62
NPV 87% (74%–95%) 86% (73
Abbreviations as in Table 3.5% CI
%–93%)
%–92%)
%–90%)
%–96%)
%–87%)
%–92%)
%–93%)
%–90%)
%–87%)
%–96%)
%–85%)
%–99%)
%–92%)
%–96%)
%–94%)
%–88%)
%–93%)
%–87%)
%–92%)
%–89%)
%–88%)
%–93%)
%–88%)
%–85%)
%–94%)
%–83%)
%–100%)
%–94%)
%–100%)
%–94%)ot employed in this study; although potentially
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942uperior to visual assessment, quantitative assess-
ent for both modalities is time and labor intensive
nd therefore not readily applicable in the clinical
etting.
Another potential limitation in our study is that
e used sulfur hexafluoride instead of the more
idely available contrast agents perflutren protein-
ype A microspheres injectable suspension (Opti-
on) and perflutren liquid microspheres injectable
uspension (Definity) because the latter were un-
vailable in the United Kingdom when the study
as commenced. We anticipate that the use of
lternative microbubble contrast agents in conjunc-
ion with adenosine will generate comparable re-
ults because these agents have been used effectively
or perfusion imaging with other stressors (29).
owever, this hypothesis requires formal testing,
deally in a large, multicenter study.
In our study, we chose not to use the flash
eplenishment technique. Theoretically, the use of
ash replenishment may have enhanced sensitivity,
articularly for the detection of intermediate-grade
tenoses and in the identification of multivessel
isease. Although previous studies have raised con-
erns about the safety of this technique, a recent
arge series confirmed the safe use of flash replen-
shment (30–33). Nevertheless, an important goal
n our study was to develop a rapid screening test, to
acilitate workflow in the clinical environment while
chieving favorable patient tolerability. Althoughmagnetic resonance imaging in the
detection of coronary artery disease: a for the detectiondamole MCE, this technique is less suited to the
horter adenosine protocol. Yet, in our study, we are
ncouraged by the achievement, even without flash
eplenishment, of diagnostic performance compa-
able to that of high field-strength CMR. A prag-
atic approach in future studies may be to employ
ash replenishment in selected cases, if no abnor-
ality is initially detected on steady-state imaging.
O N C L U S I O N S
n conclusion, we have demonstrated the favorable
iagnostic performance of a simplified adenosine
CE protocol in identifying both the presence of
oronary stenosis and its functional significance.
oreover, the performance of MCE in diagnosing
ignificant anatomic disease is comparable to that of
igh field-strength CMR imaging. The results of
ur small pilot study warrant further confirmation
n larger, multicenter studies. If realized, adenosine
CE could be added to the diagnostic armamen-
arium as a useful clinical screening test, combining
he favorable diagnostic performance and safety
rofile of adenosine with the simplicity and bedside
onvenience of transthoracic echocardiography.
eprint requests and correspondence: Prof. Joseph B. Sel-
anayagam, Department of Cardiovascular Medicine, Flin-
ers University, Flinders Medical Centre, Bedford Park,
delaide, 5042, Australia. E-mail: joseph.selvanayagam@flash replenishment is readily applicable with dipyr- flinders.edu.au.1
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